Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Legacy Reserves Inc. - Common Stock (NY:LGCY)

10.69 -0.58 (-5.15%)
Official Closing Price Updated: 8:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Legacy Reserves Inc. - Common Stock

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
10 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For February 13, 2025
 
Via Benzinga
4 Analysts Have This To Say About Legacy Education
 
Via Benzinga
Earnings Scheduled For May 15, 2025
 
Via Benzinga
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
No Fear And No Panic After A 10% Correction = No Bottom
In this video lesson, I discuss the overall market, my books, and my game plan moving forward after Friday's ugly sell-off. 
Via Talk Markets
Topics Stocks / Equities
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Self-Driving Startup Pony.ai Files For U.S. IPO
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group... 
Via Talk Markets
Topics Initial Public Offering
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Obesity Drug Developer BioAge Makes Nasdaq Debut
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.